Partner
CurrentInvesting at the intersection of Healthcare, Life Sciences, and Artificial Intelligence: https://www.aixventures.com/
Aug 2024 - Present
AeroLeads people directory · profile
Krish W. Ramadurai Email & Phone Number
Partner at AIX Ventures | Author
at
AIX Ventures
2 work emails found
@harvard.edu
LinkedIn matched
4 data sources
Profile completeness 100%
Current company
Role
Partner at AIX Ventures | Author
Location
San Francisco, California, United States
Who is Krish W. Ramadurai? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Krish W. Ramadurai is listed as Partner at AIX Ventures | Author at AIX Ventures, based in San Francisco, California, United States. AeroLeads shows a work email signal at harvard.edu and a matched LinkedIn profile for Krish W. Ramadurai.
Krish W. Ramadurai previously worked as Partner at Aix Ventures and Investor at Vevo Therapeutics. Krish W. Ramadurai holds Dphil (Phd), Engineering Science from University Of Oxford.
Company email context
Email format at AIX Ventures
This section adds company-level context without repeating Krish W. Ramadurai's masked contact details.
*@harvard.edu
71% confidence
AeroLeads found 2 current-domain work email signals for Krish W. Ramadurai. Compare company email patterns before reaching out.
Profile bio
About Krish W. Ramadurai
Krish is a Partner at AIX Ventures, where he leads the firm's technical due diligence, investment sourcing, and portfolio operational support across their artificial intelligence, healthcare, and life sciences practices. He has led and managed 40+ early and growth stage investments across multiple top-decile performing funds with a cumulative portfolio enterprise value of $10B+ and an extensive track record of success with exits including Volumetric Biotechnologies (Acquired by 3D Systems), PathologyWatch (Acquired by Sonic Healthcare), Trials.AI (Acquired by ZS Associates), and Insilico Medicine (IPO Announced). He has backed over 20 major scientific breakthroughs spanning the world's first AI-designed drug in human trials and the first drug discovered through a 3D bioprinted tissue disease model to the launch of the first commercial rideshare satellite into space. Furthermore, he is a Harvard & Oxford-trained scientist and biomolecular engineer, multi-published author, advisor, lecturer, and former researcher at Harvard & MIT. While at Harvard, he worked with former United States Secretary of Defense Ash Carter and Nobel Laureate Economist Michael Kremer on the United States Agency for International Development (USAID) Development Innovation Ventures Fund and published three internationally-released books on applied engineering and medicine featured in Barnes & Noble and the Oxford, MIT, Harvard, Yale, and Princeton library collections. He has held chairman and board positions for multiple companies and is a venture advisor for Nucleate and the National Venture Capital Association (NVCA) Venture Forward Program, and a member of Oxford University's Institute of Biomedical Engineering (IBME), American Society of Biomechanics (ASB), the American Institute of Chemical Engineers (AIChE), and the Advanced Research Projects Agency for Health (ARPA-H). His thought leadership on AI-enabled life sciences, healthcare, and technology has been featured in leading media outlets, including the Wall Street Journal, Venture Capital Journal, Yahoo Finance, NBC, World Economic Forum, Economy Middle East, TechBullion, Apple Podcasts, Funds Europe Magazine, Pulse 2.0, and Nikkei Asia.
Listed skills include Teamwork, Research, Spanish, Data Analysis, and 19 others.
Current workplace
Krish W. Ramadurai's current company
Company context helps verify the profile and gives searchers a useful next step.
46 roles
Krish W. Ramadurai work experience
A career timeline built from the work history available for this profile.
Investor
Current
Aug 2024 - Present
Investor
Current
Aug 2024 - Present
Investor
Current
Aug 2024 - Present
Investor
Current
Aug 2024 - Present
Investor
Current
Aug 2024 - Present
Investor
Current
Aug 2024 - Present
Guest Lecturer
CurrentInvited lecturer in the Faculty of Arts & Sciences for undergraduate and graduate Tissue Engineering for Clinical Applications and Biochemical Engineering & Synthetic Life courses with 25+ lectures given to date
May 2017 - Present
Investor Member
CurrentInvestor Catalyst Hub Spoke Member
Oct 2024 - Present
Venture Mentor
Current
Apr 2023 - Present
Venture Advisor
CurrentNucleate is dedicated to empowering the next generation of biotech leaders who transform experiments into enterprises
Oct 2021 - Present
Board Chairman & Investor
Jun 2023 - Aug 2024
Board Observer & Investor
Aug 2022 - Aug 2024
Board Observer & Investor
Jan 2022 - Aug 2024
Investor
Sep 2021 - Aug 2024
Investor
Aug 2021 - Aug 2024
Investor
Jul 2021 - Aug 2024
Investor
Jul 2021 - Aug 2024
Investor
Apr 2021 - Aug 2024
Investor
Apr 2021 - Aug 2024
Investor
Mar 2021 - Aug 2024
Investor
Mar 2021 - Aug 2024
Partner
- Managed top-decile performing venture capital fund with a proven track record of 40+ investments in healthcare, life sciences, and deep technology with a cumulative portfolio enterprise valuation of $7B+ across Funds I.
- Sourced and led due diligence for 30 investments across early and growth stages, composed in-depth investment memorandums for investment committees, and built a multi-stage diligence process and deal assessment.
- Spearheaded investment practices across life sciences, healthcare, artificial intelligence, and deep technology infrastructure sectors.
- Developed a proprietary investment sourcing pipeline of 4,000+ opportunities screened and conducted extensive buy-side market and technical research to develop the firm’s portfolio sector and stage allocation model.
- Composed 50+ in-depth investment memorandums for investment committees, conducted quarterly portfolio monitoring and reporting, and led deal negotiations, including structuring, financing, and closing transactions.
- Operationally supported 40 portfolio companies with multiple board-level positions and assisted CEOs with $250M+ in capital raises, M&A diligence, technology development, executive hiring, and launching 5+ products to.
Nov 2020 - Aug 2024
Principal
- Implemented institutional due diligence process and led investment analysis, technical diligence, and deal sourcing in building top-decile performing Fund I.
Sep 2020 - Nov 2020
Senior Associate
Apr 2020 - Sep 2020
Analyst
Nov 2019 - Apr 2020
Investor
Nov 2020 - Aug 2024
Investor
Nov 2020 - Aug 2024
Investor
Aug 2020 - Aug 2024
Investor
Aug 2020 - Aug 2024
Investor
Aug 2020 - Aug 2024
Investor
Jul 2020 - Aug 2024
Investor
Jun 2020 - Aug 2024
Investor
May 2020 - Aug 2024
Investor
May 2020 - Aug 2024
Investor
Apr 2020 - Aug 2024
Investor
Apr 2020 - Aug 2024
Investor
Mar 2020 - Aug 2024
Investor
Mar 2020 - Aug 2024
Investor
Feb 2020 - Aug 2024
Dec 2020 - Jan 2024
Dec 2020 - Jan 2023
Jun 2020 - May 2022
Research Assistant
- Evaluated over $1 billion in VC-funded and bootstrapped entrepreneurial business ventures using 3 statement and excel-based financial models to forecast financing activity. The resulting analysis was used in MIT case.
- Developed written briefs and reports examining bootstrapped startups, critically analyzing the deployment of innovation taxonomies in early-stage entrepreneurial ventures.
- Research featured in the book: “Reimagining Innovation in Humanitarian Medicine” (Springer-Nature Press, 2018).
Nov 2017 - Mar 2019
Research Assistant
- Collaborated on the Science, Technology, and Globalization Project with Calestous Juma, Ph.D. focusing on the applications of cutting-edge technology to improve human health and economic development in 10+ African.
- Researched affordable healthcare solutions and biomedical device applications in low-resource settings to improve the health outcomes for 50+ million people in sub-Saharan Africa.
- Resulting research was published in the internationally-released scientific book “Bio-Based Material as Applicable, Accessible, and Affordable Healthcare Solutions” (2018).
May 2017 - Jun 2018
Research Assistant
- Conducted portfolio analysis on the United States Agency for International Development (USAID) Development Innovation Ventures portfolio ($149M portfolio, 190+ investments, 5x ROI) with Nobel Laureate Economist.
- Portfolio and investment analysis work published in the governmental report “Lower Bounds on the benefit-cost ratio and social rate of Return of USAID’s Development Innovation Ventures Portfolio”.
Feb 2016 - Jul 2017
5 education records
Krish W. Ramadurai education
Dphil (Phd), Engineering Science
University Of Oxford
Msc, Nanotechnology For Medicine (Nanomedicine)
University Of Oxford
Mba
Washington University In St. Louis - Olin Business School
Master'S Degree, Biology
Harvard University
Bachelor'S Degree, Integrative Biology And Economics With Chemistry Minor
University Of Illinois Urbana-Champaign
FAQ
Frequently asked questions about Krish W. Ramadurai
Quick answers generated from the profile data available on this page.
What company does Krish W. Ramadurai work for?
Krish W. Ramadurai works for AIX Ventures.
What is Krish W. Ramadurai's role at AIX Ventures?
Krish W. Ramadurai is listed as Partner at AIX Ventures | Author at AIX Ventures.
What is Krish W. Ramadurai's email address?
AeroLeads has found 2 work email signals at @harvard.edu for Krish W. Ramadurai at AIX Ventures.
Where is Krish W. Ramadurai based?
Krish W. Ramadurai is based in San Francisco, California, United States while working with AIX Ventures.
What companies has Krish W. Ramadurai worked for?
Krish W. Ramadurai has worked for Aix Ventures, Vevo Therapeutics, Ellipsis Health, Ambience Healthcare, and Profluent.
How can I contact Krish W. Ramadurai?
You can use AeroLeads to view verified contact signals for Krish W. Ramadurai at AIX Ventures, including work email, phone, and LinkedIn data when available.
What schools did Krish W. Ramadurai attend?
Krish W. Ramadurai holds Dphil (Phd), Engineering Science from University Of Oxford.
What skills is Krish W. Ramadurai known for?
Krish W. Ramadurai is listed with skills including Teamwork, Research, Spanish, Data Analysis, Microsoft Excel, Microsoft Office, Leadership, and Project Management.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial